It can decrease the pain and swelling of arthritis. It may prevent joint damage and reduce the risk of long-term disability. Hg wang chloroquine Plaquenil and sjogren's It is important to promptly report any changes in vision, especially any changes in your central vision whilst you are on Plaquenil. It is also useful to check your central and near central vision regularly. It is recommended that you check you vision on an Amsler chart weekly see below. In rare cases, Plaquenil can adversely affect the eyes, and patients taking this medicine should be seen by an ophthalmologist at least once a year. Leflunomide works. What is hydroxychloroquine Plaquenil, Plaquenil Sulfate, Quineprox? Hydroxychloroquine is used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. Today, it is used to treat rheumatoid arthritis, some symptoms of lupus, childhood arthritis (or juvenile idiopathic arthritis) and other autoimmune diseases. Hydroxychloroquine is in a class of medications that was first used to prevent and treat malaria. Plaquenil charting Plaquenil Dosage Guide -, DMARDs for Treating Rheumatoid Arthritis Affects of stopping plaquenilHydroxychloroquine dose dialysisPlaquenil weight loss PLAQUENIL prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects. PLAQUENIL Dosage & Rx Info Uses, Side Effects. Plaquenil Hydroxychloroquine Side effects, Images, Uses.. Early Plaquenil Toxicity Detected without Bull’s Eye.. If you are taking Plaquenil to treat an inflammatory condition or malaria, you should be aware of the side effects that may occur to your eyes and vision. Plaquenil hydroxychloroquine is in a class of drugs called disease-modifying anti-rheumatic drugs, which are used to decrease inflammation, pain and joint damage. PLAQUENIL hydroxychloroquine sulfate tablets is indicated for the treatment of rheumatoid arthritis, and discoid and systemic lupus erythematosus, in patients who have not responded satisfactorily to drugs with less potential for serious side effects. Background The American Academy of Ophthalmology recommendations on screening for chloroquine CQ and hydroxychloroquine HCQ retinopathy are revised in light of new information about the prevalence of toxicity, risk factors, fundus distribution, and effectiveness of screening tools.